Tretinoin Patent Expiration

Tretinoin was first introduced by Valeant International Barbados Srl in its drug Retin-A on Approved Prior to Jan 1, 1982. Other drugs containing Tretinoin are Retin-A-Micro, Vesanoid, Avita, Atralin, Renova, Altreno, Retin-A Micro. 20 different companies have introduced drugs containing Tretinoin.


Tretinoin Patents

Given below is the list of patents protecting Tretinoin, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Altreno US10653656 Topical pharmaceutical compositions for treating skin conditions Aug 22, 2038 Dow Pharm
Altreno US11324710 Topical pharmaceutical compositions for treating skin conditions Aug 22, 2038 Dow Pharm
Altreno US6517847 Topical gel delivery system Aug 03, 2020

(Expired)

Dow Pharm
Atralin US5670547 Moisturizing vehicle for topical application of vitamin A acid Sep 23, 2014

(Expired)

Dow Pharm
Renova US6531141 Oil-in-water emulsion containing tretinoin Mar 07, 2020

(Expired)

Valeant Pharms North
Retin-a Micro US5955109 Methods and compositions for topical delivery of retinoic acid Sep 21, 2016

(Expired)

Bausch
Retin-a-micro US5955109 Methods and compositions for topical delivery of retinoic acid Sep 21, 2016

(Expired)

Bausch


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Tretinoin Generics

Several generic applications have been filed for Tretinoin. The first generic version for Tretinoin was by Teva Pharmaceuticals Usa and was approved on Jun 19, 1998. And the latest generic version is by Alembic Pharmaceuticals Ltd and was approved on Apr 29, 2024.

Given below is the list of companies who have filed for Tretinoin generic.


1. WOCKHARDT

Wockhardt Eu Operations (swiss) Ag has filed for 1 generic for Tretinoin. Given below are the details of the strengths of this generic introduced by Wockhardt.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05% solution Discontinued TOPICAL N/A Jan 25, 1999


2. ZO SKIN HEALTH

Zo Skin Health has filed for 1 generic for Tretinoin. Given below are the details of the strengths of this generic introduced by Zo Skin Health.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05% cream Discontinued TOPICAL N/A Sep 15, 2005


3. MYLAN

Mylan Pharmaceuticals Inc has filed for 3 different strengths of generic version for Tretinoin. Given below are the details of the strengths of this generic introduced by Mylan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1% gel Discontinued TOPICAL N/A Jul 17, 2013
0.04% gel Discontinued TOPICAL N/A Jul 17, 2013
0.05% gel Prescription TOPICAL AB Aug 13, 2015


4. TARO

Taro Pharmaceuticals Inc has filed for 3 different strengths of generic version for Tretinoin. Given below are the details of the strengths of this generic introduced by Taro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1% cream Prescription TOPICAL AB Jan 22, 2019
0.05% cream Prescription TOPICAL AB1 Jan 25, 2019
0.025% cream Prescription TOPICAL AB Jan 5, 2023


5. ENCUBE

Encube Ethicals Private Ltd has filed for 1 generic for Tretinoin. This 0.08% version comes by the name TRETINOIN MICROSPHERE. Given below are the details of the strengths of this generic introduced by Encube.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.08% gel Prescription TOPICAL AB Aug 22, 2023


6. TEVA PHARMS

Teva Pharmaceuticals Usa has filed for 1 generic for Tretinoin. Given below are the details of the strengths of this generic introduced by Teva Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05% solution Discontinued TOPICAL N/A Jun 19, 1998


7. BARR LABS INC

Barr Laboratories Inc has filed for 1 generic for Tretinoin. Given below are the details of the strengths of this generic introduced by Barr Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG

(reference standard)

capsule Prescription ORAL AB Jun 22, 2007


8. ENDO OPERATIONS

Endo Operations Ltd has filed for 1 generic for Tretinoin. Given below are the details of the strengths of this generic introduced by Endo Operations.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG capsule Prescription ORAL AB Oct 24, 2012


9. PADAGIS US

Padagis Us Llc has filed for 4 different strengths of generic version for Tretinoin. Given below are the details of the strengths of this generic introduced by Padagis Us.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.025% gel Prescription TOPICAL AB Feb 22, 2000
0.1% cream Prescription TOPICAL AB Dec 24, 1998
0.05% cream Prescription TOPICAL AB1 Dec 24, 1998
0.01% gel Prescription TOPICAL AB Jun 11, 2002


10. ZYDUS LIFESCIENCES

Zydus Lifesciences Ltd has filed for 1 generic for Tretinoin. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1% cream Prescription TOPICAL AB Apr 25, 2024


11. ALLERGAN

Allergan Sales Llc has filed for 2 different strengths of generic version for Tretinoin. Given below are the details of the strengths of this generic introduced by Allergan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.0375% cream Discontinued TOPICAL N/A Mar 22, 2010
0.075% cream Discontinued TOPICAL N/A Oct 11, 2012


12. GLENMARK PHARMS LTD

Glenmark Pharmaceuticals Ltd has filed for 1 generic for Tretinoin. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG capsule Prescription ORAL AB Dec 23, 2016


13. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 1 generic for Tretinoin. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1% cream Prescription TOPICAL AB Apr 29, 2024